Title:
治療薬414
Document Type and Number:
Japanese Patent JP2011529955
Kind Code:
A
Abstract:
A compound of Formula (I): is useful in the treatment or prevention of a disease or medical condition mediated through glucokinase (GLK or GK), leading to a decreased glucose threshold for insulin secretion.
Inventors:
Bennett, Stuart Norman Lyle
Bonn, Peter Gustav
Blink, Michael Dunn
Batlin, Roger John
Campbell, Leonie
Davis, Robert Darren Morse
Fjällhag, Jonas Ricardo
Yurva, Ulreuk
Helen Claire, Pointon
Rob, Graem Richard
Schöneck, Volkel
Svenson Henrixon, Annette Marie
Walker, Rolf Peter
Walling, Michael James
Westerlund, Christel Ralph
Bonn, Peter Gustav
Blink, Michael Dunn
Batlin, Roger John
Campbell, Leonie
Davis, Robert Darren Morse
Fjällhag, Jonas Ricardo
Yurva, Ulreuk
Helen Claire, Pointon
Rob, Graem Richard
Schöneck, Volkel
Svenson Henrixon, Annette Marie
Walker, Rolf Peter
Walling, Michael James
Westerlund, Christel Ralph
Application Number:
JP2011521643A
Publication Date:
December 15, 2011
Filing Date:
August 03, 2009
Export Citation:
Assignee:
AstraZeneca Activrag
International Classes:
C07D487/04; A61K31/519; A61K45/00; A61P3/04; A61P3/06; A61P3/08; A61P3/10; A61P43/00; C07B53/00; C07C67/31; C07C69/708
Attorney, Agent or Firm:
Shinjiro Ono
Yasushi Kobayashi
Akio Chiba
Hiroyuki Tomita
Yasushi Kobayashi
Akio Chiba
Hiroyuki Tomita